Dyslexia Treatment Market Research Report Information by Type (Phonological Dyslexia, Surface Dyslexia, Others), Treatment & Diagnosis (Treatment {Medications [Antihistamines, Central Nervous Stimulant, Anti-Myoclonic, Attention-Deficit Hyperactivity Disorder (ADHD) Drug, and Others], Tools [E-Readers and Tablets, Apps, Smartpens, and Others]}, DIAGNOSIS {Paper-Based and Digital-Based}), By End Users (Specialty Center, Home Care, Hospitals & Clinics, and Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - F

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING PREVALENCE OF DYSLEXIA

4.2.2 INCREASING APP DEVELOPMENT ACTIVITIES TO TREAT DYSLEXIA

4.2.3 GROWING NUMBER OF VITUAL REALITY-BASED EDUCATIONAL SOFTWARE

4.3 RESTRAINT

4.3.1 LACK OF AWARENESS ABOUT DYSLEXIA, ITS SYMPTOMS AND UNDERDIAGNOSIS

4.4 OPPORTUNITY

4.4.1 COLLABORATION WITH SCHOOLS, COLLEGES AND NON PROFIT ORGANIZATIONS

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 RESEARCH & DEVELOPMENT

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION

5.1.4 MARKETING & SALES

5.1.5 POST-SALES MONITORING

5.1.6 INPUTS

5.1.7 SOFTWARE DEVELOPMENT PROCESSES

5.1.8 OUTPUT

5.1.9 MARKETING AND DISTRIBUTION

5.1.10 POST-SELLING SERVICES

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 BARGAINING POWER OF BUYERS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF NEW ENTRANTS

5.2.4 THREAT OF SUBSTITUTES

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19

5.4 DYSLEXIA DIAGNOSIS

5.5 DYSLEXIA TREATMENT

5.6 STANDARD PAPER TESTS VS ELECTRONIC VERSIONS

5.6.1 TESTS FOR DYSLEXIA AND LEARNING DISABILITIES (PRE-SCHOOLERS)

6 GLOBAL DYSLEXIA TREATMENT & DIAGNOSIS MARKET BY TYPE

6.1 OVERVIEW

6.2 PHONOLOGICAL DYSLEXIA

6.3 SURFACE DYSLEXIA

6.4 OTHERS

7 GLOBAL DYSLEXIA TREATMENT & DIAGNOSIS MARKET BY TREATMENT & DIAGNOSIS

7.1 OVERVIEW

7.2 TREATMENT

7.2.1 MEDICATIONS

7.2.1.1 ANTIHISTAMINES

7.2.1.2 CENTRAL NERVOUS STIMULANT

7.2.1.3 ANTI-MYOCLONIC

7.2.1.4 ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD) DRUG

7.2.1.5 OTHERS

7.2.2 TOOLS

7.2.2.1 E-READERS AND TABLETS

7.2.2.2 APPS

7.2.2.3 SMARTPENS

7.2.2.4 OTHERS

7.3 DIAGNOSIS

7.3.1 PAPER-BASED

7.3.2 DIGITAL-BASED

8 GLOBAL DYSLEXIA TREATMENT & DIAGNOSIS MARKET BY END USER

8.1 OVERVIEW

8.2 SPECIALTY CENTER

8.3 HOME CARE

8.4 HOSPITALS & CLINICS

8.5 OTHERS

9 GLOBAL DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY REGION

9.1 OVERVIEW

9.2 NORTH AMERICA

9.2.1 US

9.2.2 CANADA

9.3 EUROPE

9.3.1 GERMANY

9.3.2 UK

9.3.3 FRANCE

9.3.4 ITALY

9.3.5 SPAIN

9.3.6 REST OF EUROPE

9.4 ASIA PACIFIC

9.4.1 CHINA

9.4.2 JAPAN

9.4.3 INDIA

9.4.4 AUSTRALIA

9.4.5 SOUTH KOREA

9.4.6 REST OF ASIA-PACIFIC

9.5 REST OF THE WORLD

9.5.1 LATIN AMERICA

9.5.2 MIDDLE EAST

9.5.3 AFRICA

10 COMPETITIVE LANDSCAPE

10.1 COMPETITIVE OVERVIEW

10.2 MAJOR PLAYERS IN THE GLOBAL DYSLEXIA TREATMENT MARKET

10.3 MAJOR GROWTH STRATEGIES IN THE GLOBAL DYSLEXIA TREATMENT MARKET

10.4 COMPETITIVE BENCHMARKING

10.5 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL DYSLEXIA TREATMENT MARKET

10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

10.6.1 NEW PRODUCT DEVELOPMENTS/LAUNCHES

10.6.2 COLLABORATIONS/EXPANSIONS/PARTNERSHIPS/INVESTMENTS

10.7 MAJOR PLAYERS FINANCIAL MATRIX

10.7.1 REVENUE OF MAJOR PLAYERS, 2020

10.7.2 R&D EXPENDITURE, 2020

11 COMPANY PROFILES

11.1 PFIZER INC.

11.1.1 COMPANY OVERVIEW

11.1.2 FINANCIAL OVERVIEW

11.1.3 PRODUCTS OFFERED

11.1.4 KEY DEVELOPMENTS

11.1.5 SWOT ANALYSIS

11.1.6 KEY STRATEGIES

11.2 SPEECHIFY INC.

11.2.1 COMPANY OVERVIEW

11.2.2 FINANCIAL OVERVIEW

11.2.3 PRODUCTS OFFERED

11.2.4 KEY DEVELOPMENTS.

11.2.5 KEY STRATEGIES

11.3 JUBILANT PHARMA LIMITED

11.3.1 COMPANY OVERVIEW

11.3.2 FINANCIAL OVERVIEW

11.3.3 PRODUCTS/SERVICES OFFERED

11.3.4 KEY DEVELOPMENTS

11.3.5 KEY STRATEGIES

11.4 LINGIT AS

11.4.1 COMPANY OVERVIEW

11.4.2 FINANCIAL OVERVIEW

11.4.3 PRODUCTS OFFERED

11.4.4 KEY DEVELOPMENTS

11.4.5 KEY STRATEGIES

11.5 SOLI

11.5.1 COMPANY OVERVIEW

11.5.2 FINANCIAL OVERVIEW

11.5.3 PRODUCTS OFFERED

11.5.4 KEY DEVELOPMENTS

11.5.5 KEY STRATEGIES

11.6 NOVARTIS AG

11.6.1 COMPANY OVERVIEW

11.6.2 FINANCIAL OVERVIEW

11.6.3 PRODUCTS/SERVICES OFFERED

11.6.4 KEY DEVELOPMENTS

11.6.5 SWOT ANALYSIS

11.6.6 KEY STRATEGIES

11.7 LYFTA

11.7.1 COMPANY OVERVIEW

11.7.2 FINANCIAL OVERVIEW

11.7.3 PRODUCTS/SERVICES OFFERED

11.7.4 KEY DEVELOPMENTS

11.7.5 KEY STRATEGIES

11.8 GLAXOSMITHKLINE

11.8.1 COMPANY OVERVIEW

11.8.2 FINANCIAL OVERVIEW

11.8.3 PRODUCTS OFFERED

11.8.4 KEY DEVELOPMENTS

11.8.5 SWOT ANALYSIS

11.8.6 KEY STRATEGIES

11.9 TEVA PHARMACEUTICAL INDUSTRIES LTD.

11.9.1 COMPANY OVERVIEW

11.9.2 FINANCIAL OVERVIEW

11.9.3 PRODUCTS/SERVICES OFFERED

11.9.4 KEY DEVELOPMENTS

11.9.5 SWOT ANALYSIS

11.9.6 KEY STRATEGIES

11.10 ELI LILLY & COMPANY

11.10.1 COMPANY OVERVIEW

11.10.2 FINANCIAL OVERVIEW

11.10.3 PRODUCTS/SERVICES OFFERED

11.10.4 KEY DEVELOPMENTS

11.10.5 SWOT ANALYSIS

11.10.6 KEY STRATEGIES

11.11 RPG LIFE SCIENCES LTD

11.11.1 COMPANY OVERVIEW

11.11.2 FINANCIAL OVERVIEW

11.11.3 PRODUCTS/SERVICES OFFERED

11.11.4 KEY DEVELOPMENTS

11.11.5 KEY STRATEGIES

11.12 HOPALAI D.O.O.

11.12.1 COMPANY OVERVIEW

11.12.2 FINANCIAL OVERVIEW

11.12.3 PRODUCTS/SERVICES OFFERED

11.12.4 KEY DEVELOPMENTS

11.12.5 KEY STRATEGIES

12 APPENDIX

12.1 REFERENCES

12.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 APPLICATION DEVELPOPED SPECIFICALLY FOR DYSLEXIA

TABLE 4 FREE APPS FOR DYSLEXIA

TABLE 5 DYSLEXIA SCHOOLS IN CANADA

TABLE 6 DYSLEXIA SCHOOLS IN THE UK

TABLE 7 DYSLEXIA SCHOOLS IN THE UK

TABLE 8 DYSLEXIA AND LEARNING DISABILITIES TESTS FOR PRE-SCHOOLERS (BIRTH – 5 YEARS):

TABLE 9 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY SHOULDER TYPE, 2023-2032 (USD MILLION)

TABLE 10 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY PHONOLOGICAL DYSLEXIA, 2023–2032 (USD MILLION)

TABLE 11 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR SURFACE DYSLEXIA, BY REGION, 2023–2032 (USD MILLION)

TABLE 12 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR OTHERS, BY REGION, 2023–2032 (USD MILLION)

TABLE 13 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023-2032 (USD MILLION)

TABLE 14 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TREATMENT, BY REGION, 2023–2032 (USD MILLION)

TABLE 15 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)

TABLE 16 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR MEDICATIONS, BY REGION, 2023–2032 (USD MILLION)

TABLE 17 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR MEDICATIONS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 18 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR ANTIHISTAMINES, BY REGION, 2023–2032 (USD MILLION)

TABLE 19 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR CENTRAL NERVOUS STIMULANT, BY REGION, 2023–2032 (USD MILLION)

TABLE 20 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR ANTI-MYOCLONIC, BY REGION, 2023–2032 (USD MILLION)

TABLE 21 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD) DRUG, BY REGION, 2023–2032 (USD MILLION)

TABLE 22 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR OTHERS, BY REGION, 2023–2032 (USD MILLION)

TABLE 23 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TOOLS, BY REGION, 2023–2032 (USD MILLION)

TABLE 24 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TOOLS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 25 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR E-READERS AND TABLETS, BY REGION, 2023–2032 (USD MILLION)

TABLE 26 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR APPS, BY REGION, 2023–2032 (USD MILLION)

TABLE 27 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR SMARTPENS, BY REGION, 2023–2032 (USD MILLION)

TABLE 28 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR OTHERS, BY REGION, 2023–2032 (USD MILLION)

TABLE 29 COMMON CLINICAL TESTS PERFORMED TO DIAGNOSE DYSLEXIA

TABLE 30 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR DIAGNOSIS, BY REGION, 2023–2032 (USD MILLION)

TABLE 31 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 32 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR PAPER-BASED, BY REGION, 2023–2032 (USD MILLION)

TABLE 33 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR DIGITAL-BASED, BY REGION, 2023–2032 (USD MILLION)

TABLE 34 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023-2032 (USD MILLION)

TABLE 35 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR SPECIALTY CENTER, BY REGION, 2023–2032 (USD MILLION)

TABLE 36 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR HOME CARE, BY REGION, 2023–2032 (USD MILLION)

TABLE 37 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2023–2032 (USD MILLION)

TABLE 38 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR OTHERS, BY REGION, 2023–2032 (USD MILLION)

TABLE 39 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY REGION, 2023–2032 (USD MILLION)

TABLE 40 NORTH AMERICA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY COUNTRY, 2023–2032 (USD MILLION)

TABLE 41 NORTH AMERICA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023–2032 (USD MILLION)

TABLE 42 NORTH AMERICA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)

TABLE 43 NORTH AMERICA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)

TABLE 44 NORTH AMERICA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR MEDICATION, BY TYPE, 2023–2032 (USD MILLION)

TABLE 45 NORTH AMERICA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TOOLS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 46 NORTH AMERICA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 47 NORTH AMERICA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023–2032 (USD MILLION)

TABLE 48 US: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023–2032 (USD MILLION)

TABLE 49 US: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)

TABLE 50 US: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)

TABLE 51 US: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR MEDICATION, BY TYPE, 2023–2032 (USD MILLION)

TABLE 52 US: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TOOLS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 53 US: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 54 US: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023–2032 (USD MILLION)

TABLE 55 CANADA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023–2032 (USD MILLION)

TABLE 56 CANADA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)

TABLE 57 CANADA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)

TABLE 58 CANADA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR MEDICATION, BY TYPE, 2023–2032 (USD MILLION)

TABLE 59 CANADA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR TOOLS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 60 CANADA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 61 CANADA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023–2032 (USD MILLION)

TABLE 62 EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION)

TABLE 63 EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023-2032 (USD MILLION)

TABLE 64 EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023-2032 (USD MILLION)

TABLE 65 EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION)

TABLE 66 EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TOOLS, BY TYPE, 2023-2032 (USD MILLION)

TABLE 67 EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023-2032 (USD MILLION)

TABLE 68 EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023-2032 (USD MILLION)

TABLE 69 GERMANY DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION)

TABLE 70 GERMANY DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023-2032 (USD MILLION)

TABLE 71 GERMANY DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023-2032 (USD MILLION)

TABLE 72 GERMANY DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION)

TABLE 73 GERMANY DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TOOLS, BY TYPE, 2023-2032 (USD MILLION)

TABLE 74 GERMANY DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023-2032 (USD MILLION)

TABLE 75 GERMANY DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023-2032 (USD MILLION)

TABLE 76 UK DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION)

TABLE 77 UK DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023-2032 (USD MILLION)

TABLE 78 UK DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023-2032 (USD MILLION)

TABLE 79 UK DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION)

TABLE 80 UK DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TOOLS, BY TYPE, 2023-2032 (USD MILLION)

TABLE 81 UK DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023-2032 (USD MILLION)

TABLE 82 UK DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023-2032 (USD MILLION)

TABLE 83 FRANCE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION)

TABLE 84 FRANCE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023-2032 (USD MILLION)

TABLE 85 FRANCE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023-2032 (USD MILLION)

TABLE 86 FRANCE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION)

TABLE 87 FRANCE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TOOLS, BY TYPE, 2023-2032 (USD MILLION)

TABLE 88 FRANCE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023-2032 (USD MILLION)

TABLE 89 FRANCE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023-2032 (USD MILLION)

TABLE 90 ITALY DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION)

TABLE 91 ITALY DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023-2032 (USD MILLION)

TABLE 92 ITALY DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023-2032 (USD MILLION)

TABLE 93 ITALY DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION)

TABLE 94 ITALY DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TOOLS, BY TYPE, 2023-2032 (USD MILLION)

TABLE 95 ITALY DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023-2032 (USD MILLION)

TABLE 96 ITALY DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023-2032 (USD MILLION)

TABLE 97 SPAIN DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION)

TABLE 98 SPAIN DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023-2032 (USD MILLION)

TABLE 99 SPAIN DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023-2032 (USD MILLION)

TABLE 100 SPAIN DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION)

TABLE 101 SPAIN DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TOOLS, BY TYPE, 2023-2032 (USD MILLION)

TABLE 102 SPAIN DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023-2032 (USD MILLION)

TABLE 103 SPAIN DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023-2032 (USD MILLION)

TABLE 104 REST OF EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023-2032 (USD MILLION)

TABLE 105 REST OF EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023-2032 (USD MILLION)

TABLE 106 REST OF EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023-2032 (USD MILLION)

TABLE 107 REST OF EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATION, BY TYPE, 2023-2032 (USD MILLION)

TABLE 108 REST OF EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TOOLS, BY TYPE, 2023-2032 (USD MILLION)

TABLE 109 REST OF EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023-2032 (USD MILLION)

TABLE 110 REST OF EUROPE DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023-2032 (USD MILLION)

TABLE 111 ASIA PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY COUNTRY, 2023–2032 (USD MILLION)

TABLE 112 ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023–2032 (USD MILLION)

TABLE 113 ASIA-PACIFIC DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)

TABLE 114 ASIA-PACIFIC DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)

TABLE 115 ASIA-PACIFIC DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATIONS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 116 ASIA-PACIFIC DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TOOLS, 2023–2032 (USD MILLION)

TABLE 117 ASIA-PACIFIC DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 118 ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023–2032 (USD MILLION)

TABLE 119 CHINA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023–2032 (USD MILLION)

TABLE 120 CHINA DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)

TABLE 121 CHINA DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)

TABLE 122 CHINA DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATIONS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 123 CHINA DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TOOLS, 2023–2032 (USD MILLION)

TABLE 124 CHINA DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 125 CHINA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023–2032 (USD MILLION)

TABLE 126 JAPAN: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023–2032 (USD MILLION)

TABLE 127 JAPAN: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)

TABLE 128 JAPAN: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)

TABLE 129 JAPAN: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATIONS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 130 JAPAN: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TOOLS, 2023–2032 (USD MILLION)

TABLE 131 JAPAN: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 132 JAPAN: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023–2032 (USD MILLION)

TABLE 133 INDIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023–2032 (USD MILLION)

TABLE 134 INDIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)

TABLE 135 INDIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)

TABLE 136 INDIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATIONS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 137 INDIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TOOLS, 2023–2032 (USD MILLION)

TABLE 138 INDIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 139 INDIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023–2032 (USD MILLION)

TABLE 140 AUSTRALIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023–2032 (USD MILLION)

TABLE 141 AUSTRALIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)

TABLE 142 AUSTRALIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)

TABLE 143 AUSTRALIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATIONS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 144 AUSTRALIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TOOLS, 2023–2032 (USD MILLION)

TABLE 145 AUSTRALIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 146 AUSTRALIA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023–2032 (USD MILLION)

TABLE 147 SOUTH KOREA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023–2032 (USD MILLION)

TABLE 148 SOUTH KOREA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)

TABLE 149 SOUTH KOREA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)

TABLE 150 SOUTH KOREA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATIONS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 151 SOUTH KOREA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TOOLS, 2023–2032 (USD MILLION)

TABLE 152 SOUTH KOREA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 153 SOUTH KOREA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023–2032 (USD MILLION)

TABLE 154 REST OF ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2023–2032 (USD MILLION)

TABLE 155 REST OF ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)

TABLE 156 REST OF ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)

TABLE 157 REST OF ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR MEDICATIONS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 158 REST OF ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR TREATMENT, BY TOOLS, 2023–2032 (USD MILLION)

TABLE 159 REST OF ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 160 REST OF ASIA-PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2023–2032 (USD MILLION)

TABLE 161 REST OF THE WORLD: DYSLEXIA TREATMENT MARKET, BY COUNTRY, 2023–2032 (USD MILLION)

TABLE 162 REST OF THE WORLD: DYSLEXIA TREATMENT MARKET, BY TYPE, 2023–2032 (USD MILLION)

TABLE 163 REST OF THE WORLD: DYSLEXIA TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)

TABLE 164 REST OF THE WORLD: DYSLEXIA TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)

TABLE 165 REST OF THE WORLD: DYSLEXIA TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2023–2032 (USD MILLION)

TABLE 166 REST OF THE WORLD: DYSLEXIA TREATMENT MARKET, FOR TOOLS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 167 REST OF THE WORLD: DYSLEXIA TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 168 REST OF THE WORLD: DYSLEXIA TREATMENT MARKET, BY END USER, 2023–2032 (USD MILLION)

TABLE 169 LATIN AMERICA: DYSLEXIA TREATMENT MARKET, BY TYPE, 2023–2032 (USD MILLION)

TABLE 170 LATIN AMERICA: DYSLEXIA TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)

TABLE 171 LATIN AMERICA: DYSLEXIA TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)

TABLE 172 LATIN AMERICA: DYSLEXIA TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2023–2032 (USD MILLION)

TABLE 173 LATIN AMERICA: DYSLEXIA TREATMENT MARKET, FOR TOOLS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 174 LATIN AMERICA: DYSLEXIA TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 175 LATIN AMERICA: DYSLEXIA TREATMENT MARKET, BY END USER, 2023–2032 (USD MILLION)

TABLE 176 MIDDLE EAST: DYSLEXIA TREATMENT MARKET, BY TYPE, 2023–2032 (USD MILLION)

TABLE 177 MIDDLE EAST: DYSLEXIA TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)

TABLE 178 MIDDLE EAST: DYSLEXIA TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)

TABLE 179 MIDDLE EAST: DYSLEXIA TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2023–2032 (USD MILLION)

TABLE 180 MIDDLE EAST: DYSLEXIA TREATMENT MARKET, FOR TOOLS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 181 MIDDLE EAST: DYSLEXIA TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 182 MIDDLE EAST: DYSLEXIA TREATMENT MARKET, BY END USER, 2023–2032 (USD MILLION)

TABLE 183 AFRICA: DYSLEXIA TREATMENT MARKET, BY TYPE, 2023–2032 (USD MILLION)

TABLE 184 AFRICA: DYSLEXIA TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2023–2032 (USD MILLION)

TABLE 185 AFRICA: DYSLEXIA TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2023–2032 (USD MILLION)

TABLE 186 AFRICA: DYSLEXIA TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2023–2032 (USD MILLION)

TABLE 187 AFRICA: DYSLEXIA TREATMENT MARKET, FOR TOOLS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 188 AFRICA: DYSLEXIA TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2023–2032 (USD MILLION)

TABLE 189 AFRICA: DYSLEXIA TREATMENT MARKET, BY END USER, 2023–2032 (USD MILLION)

TABLE 190 MAJOR PLAYERS IN THE GLOBAL DYSLEXIA TREATMENT MARKET

TABLE 191 THE MOST ACTIVE PLAYERS IN THE GLOBAL DYSLEXIA TREATMENT MARKET

TABLE 192 NEW PRODUCT DEVELOPMENTS/LAUNCHES/PRODUCT LICENSING AGREEMENTS

TABLE 193 COLLABORATIONS/EXPANSIONS/PARTNERSHIPS/INVESTMENTS

TABLE 194 PFIZER INC.: PRODUCTS OFFERED

TABLE 195 SPEECHIFY INC.: PRODUCTS OFFERED

TABLE 196 JUBILANT PHARMA LIMITED: PRODUCTS/SERVICES OFFERED

TABLE 197 LINGIT AS: PRODUCTS OFFERED

TABLE 198 LINGIT AS: KEY DEVELOPMENTS

TABLE 199 SOLI: PRODUCTS/SERVICES OFFERED

TABLE 200 NOVARTIS AG: PRODUCTS/SERVICES OFFERED

TABLE 201 LYFTA: PRODUCTS/SERVICES OFFERED

TABLE 202 LYFTA: KEY DEVELOPMENTS

TABLE 203 GLAXOSMITHKLINE: PRODUCTS OFFERED

TABLE 204 TEVA PHARMACEUTICAL INDUSTRIES LTD: PRODUCTS/SERVICES OFFERED

TABLE 205 TEVA PHARMACEUTICAL INDUSTRIES LTD: KEY DEVELOPMENTS

TABLE 206 ELI LILLY & COMPANY: PRODUCTS/SERVICES OFFERED

TABLE 207 RPG LIFE SCIENCES LTD: PRODUCTS/SERVICES OFFERED

TABLE 208 HOPALAI D.O.O.: PRODUCTS/SERVICES OFFERED

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 MARKET STRUCTURE: DYSLEXIA TREATMENT & DIAGNOSIS MARKET

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 4 MARKET DYNAMICS: DYSLEXIA TREATMENT & DIAGNOSIS MARKET

FIGURE 5 DRIVERS: IMPACT ANALYSIS

FIGURE 6 RESTRAINT: IMPACT ANALYSIS

FIGURE 7 VALUE CHAIN: GLOBAL DYSLEXIA TREATMENT & DIAGNOSIS MARKET

FIGURE 8 VALUE CHAIN: GLOBAL DYSLEXIA TREATMENT & DIAGNOSIS MARKET

FIGURE 9 PORTER'S FIVE FORCES ANALYSIS: GLOBAL DYSLEXIA TREATMENT & DIAGNOSIS MARKET

FIGURE 10 GLOBAL DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TYPE, 2020 & 2032 (USD MILLION)

FIGURE 11 GLOBAL DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY TREATMENT & DIAGNOSIS, 2020 & 2032 (USD MILLION)

FIGURE 12 GLOBAL DYSLEXIA TREATMENT & DIAGNOSIS MARKET, BY END USER, 2020 & 2032 (USD MILLION)

FIGURE 13 GLOBAL: DYSLEXIA TREATMENT & DIAGNOSIS MARKET SHARE (%), BY REGION, 2020

FIGURE 14 NORTH AMERICA: DYSLEXIA TREATMENT & DIAGNOSIS MARKET SHARE (%), BY COUNTRY, 2020

FIGURE 15 ASIA PACIFIC: DYSLEXIA TREATMENT & DIAGNOSIS MARKET SHARE (%), BY COUNTRY, 2020

FIGURE 16 REST OF THE WORLD: DYSLEXIA TREATMENT MARKET SHARE (%), BY COUNTRY, 2020

FIGURE 17 EXPANSION: THE MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL DYSLEXIA TREATMENT MARKET

FIGURE 18 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 19 REVENUE OF MAJOR PLAYERS, 2020

FIGURE 20 MAJOR PLAYERS R&D EXPENDITURE, 2020

FIGURE 21 PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 PFIZER INC.: SWOT ANALYSIS

FIGURE 23 JUBILANT PHARMA LIMITED: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 NOVARTIS AG: SWOT ANALYSIS

FIGURE 26 GLAXOSMITHKLINE: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 GLAXOSMITHKLINE: SWOT ANALYSIS

FIGURE 28 TEVA PHARMACEUTICAL INDUSTRIES LTD: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 TEVA PHARMACEUTICAL INDUSTRIES LTD: SWOT ANALYSIS

FIGURE 30 ELI LILLY & COMPANY: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 ELI LILLY & COMPANY: SWOT ANALYSIS

FIGURE 32 RPG LIFE SCIENCES LTD.: FINANCIAL OVERVIEW SNAPSHOT